Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and <svg style="vertical-align:-4.49648pt;width:43.174999px;" id="M1" height="21.075001" version="1.1" viewBox="0 0 43.174999 21.075001" width="43.174999"      xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,0,0,-.022,.062,15.413)"><path id="x1D736" d="M505 450h125l-163 -259q-1 -4 -1 -12q0 -19 1 -23q9 -98 41 -98q36 0 58 76l24 -7q-34 -139 -121 -139q-32 0 -57.5 24t-31.5 55q-72 -77 -181 -77q-73 0 -114 44t-41 124q0 118 79 210q79 93 197 93q51 0 86 -27t50 -71zM369 281q0 141 -62 141q-43 0 -95 -84
q-52 -82 -52 -195q0 -50 15 -83t42 -33q35 0 79 57q43 58 67 121q6 35 6 76z"/></g>

			<g transform="matrix(.016,0,0,-.016,14.05,20.8)"><path id="x1D463" d="M457 332q0 -81 -41 -161.5t-105.5 -131.5t-129.5 -51q-46 0 -79 30.5t-33 86.5q0 18 7 51q18 95 46 187q6 19 6 33q0 7 -7 7q-24 0 -78 -64l-20 23q32 48 73 77t78 29q33 0 33 -46q0 -38 -10 -70q-28 -92 -39 -152q-7 -38 -7 -57q0 -78 69 -78q68 0 118 75.5t50 194.5
q0 43 -12 57q-11 12 -11 24q0 19 15 35.5t34 16.5q18 0 30.5 -34.5t12.5 -81.5z"/></g>

			<g transform="matrix(.022,0,0,-.022,22.2,15.413)"><path id="x1D737" d="M54 -114l114 487q24 102 62.5 165t102.5 109q53 38 129 38q51 0 86 -33.5t35 -84.5q0 -57 -31.5 -105t-81.5 -68v-2q88 -14 88 -126q0 -64 -29 -127q-29 -62 -90 -107q-62 -44 -143 -44q-67 0 -97 18l-28 -124q-11 -51 -26 -87h-117q9 19 26 91zM304 480l-87 -393
q0 -29 19 -44t48 -15q63 0 110 74q46 74 46 153q0 117 -52 117q-6 0 -23.5 -3t-21.5 -3q-33 0 -33 25q0 15 15 25.5t41 10.5q8 0 30 -6q27 -5 28 -5q26 0 41 43t15 89q0 39 -17.5 62t-44.5 23q-46 0 -71 -35.5t-43 -117.5z"/></g>

			<g transform="matrix(.016,0,0,-.016,34.65,20.8)"><path id="x1D7D1" d="M58 524l-21 12q80 152 229 152q73 0 119 -41q45 -41 45 -96q0 -40 -21.5 -74.5t-62.5 -52.5q57 -20 89.5 -68.5t32.5 -109.5q0 -110 -86 -185t-214 -75q-69 0 -110.5 24.5t-41.5 65.5q0 26 18.5 43t46.5 17q45 0 96 -57q39 -43 79 -43q45 0 71.5 34t26.5 88q0 75 -49 121
q-25 23 -56 39q-34 17 -97 38v17q69 21 100 53t31 78q0 103 -99 103q-40 0 -69.5 -19t-56.5 -64z"/></g>

		
	
</svg> Integrin

<table>Immunofluorescence histochemistry of the sections from the aortic arch apoE<sup>−/−</sup> mice on a high cholesterol diet. (a) IntegriSense, (b) ProSense, red: imaging agent, green: CD 68 antibody staining monocytes/macrophages, blue: DAPI staining of cell nucleus, yellow arrows: colocalization of agents and macrophages, red arrows: distribution of agents in the core of atherosclerotic lesion, Adv: adventitia.</table>

International Journal of Molecular Imaging

fig5

Figure 5

Figure 5: Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and <svg style="vertical-align:-4.49648pt;width:43.174999px;" id="M1" height="21.075001" version="1.1" viewBox="0 0 43.174999 21.075001" width="43.174999"      xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,0,0,-.022,.062,15.413)"><path id="x1D736" d="M505 450h125l-163 -259q-1 -4 -1 -12q0 -19 1 -23q9 -98 41 -98q36 0 58 76l24 -7q-34 -139 -121 -139q-32 0 -57.5 24t-31.5 55q-72 -77 -181 -77q-73 0 -114 44t-41 124q0 118 79 210q79 93 197 93q51 0 86 -27t50 -71zM369 281q0 141 -62 141q-43 0 -95 -84
q-52 -82 -52 -195q0 -50 15 -83t42 -33q35 0 79 57q43 58 67 121q6 35 6 76z"/></g>

			<g transform="matrix(.016,0,0,-.016,14.05,20.8)"><path id="x1D463" d="M457 332q0 -81 -41 -161.5t-105.5 -131.5t-129.5 -51q-46 0 -79 30.5t-33 86.5q0 18 7 51q18 95 46 187q6 19 6 33q0 7 -7 7q-24 0 -78 -64l-20 23q32 48 73 77t78 29q33 0 33 -46q0 -38 -10 -70q-28 -92 -39 -152q-7 -38 -7 -57q0 -78 69 -78q68 0 118 75.5t50 194.5
q0 43 -12 57q-11 12 -11 24q0 19 15 35.5t34 16.5q18 0 30.5 -34.5t12.5 -81.5z"/></g>

			<g transform="matrix(.022,0,0,-.022,22.2,15.413)"><path id="x1D737" d="M54 -114l114 487q24 102 62.5 165t102.5 109q53 38 129 38q51 0 86 -33.5t35 -84.5q0 -57 -31.5 -105t-81.5 -68v-2q88 -14 88 -126q0 -64 -29 -127q-29 -62 -90 -107q-62 -44 -143 -44q-67 0 -97 18l-28 -124q-11 -51 -26 -87h-117q9 19 26 91zM304 480l-87 -393
q0 -29 19 -44t48 -15q63 0 110 74q46 74 46 153q0 117 -52 117q-6 0 -23.5 -3t-21.5 -3q-33 0 -33 25q0 15 15 25.5t41 10.5q8 0 30 -6q27 -5 28 -5q26 0 41 43t15 89q0 39 -17.5 62t-44.5 23q-46 0 -71 -35.5t-43 -117.5z"/></g>

			<g transform="matrix(.016,0,0,-.016,34.65,20.8)"><path id="x1D7D1" d="M58 524l-21 12q80 152 229 152q73 0 119 -41q45 -41 45 -96q0 -40 -21.5 -74.5t-62.5 -52.5q57 -20 89.5 -68.5t32.5 -109.5q0 -110 -86 -185t-214 -75q-69 0 -110.5 24.5t-41.5 65.5q0 26 18.5 43t46.5 17q45 0 96 -57q39 -43 79 -43q45 0 71.5 34t26.5 88q0 75 -49 121
q-25 23 -56 39q-34 17 -97 38v17q69 21 100 53t31 78q0 103 -99 103q-40 0 -69.5 -19t-56.5 -64z"/></g>

		
	
</svg> Integrin 

Figure 5 | Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and 
	
		
			

			

			

			

		
	
 Integrin 

International Journal of Molecular Imaging

Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and Integrin

Figure 5